Companies: 10,795·Total market cap: $144.5T
Zymeworks Inc.

Zymeworks Inc.

ZYMENASDAQHealthcare● Active
$23.93
$-0.11(-0.46%)
Market Cap$1.8B
P/E Ratio
52W High$29.75
52W Low$11.51
Overview

Zymeworks Inc. (ZYME) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

zyme · stock forecast · 20 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 20 Wall Street analysts in the past 3 months

SellBuy

Buy

20 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
18
Hold
2
Sell
0
Strong Sell
0
Total: 20 · Buy rate: 90.0%

12-Month Price Target

High

$48.00

Consensus

$41.75

+75.3% upside

Low

$33.00

Median: $43 · Last Close: $23.82

The Zymeworks Inc. (ZYME) analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month ZYME price target is $41.75, representing +75.3% upside from the current price of $23.82.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $42 (75.3%)

Consensus Target

$41.75

75.3% upside

High Target

$48

101.5%

Low Target

$33

38.5%

Current Price

$23.82

as of today

Based on analyst price targets, the ZYME stock price prediction for the next 12 months ranges from $33 to $48. The consensus ZYME price forecast of $41.75 implies 75.3% upside from the current price of $23.82.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$23.630.78%

1-day model range: $23.51–$23.76. Peak: $23.76 (-0.78%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$37+54.3%
2028$48+100.3%
2029$56+133.2%
2030$61+154.3%
2031+166.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)45.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ZYME · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$24.28SELL
MA 10$24.68SELL
MA 20$24.58SELL
MA 50$25.90SELL
MA 100$24.70SELL
MA 200$22.48BUY
Current $ZYME · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$24.28SELL
EMA 10$24.52SELL
EMA 20$24.87SELL
EMA 50$25.20SELL
EMA 100$24.58SELL
EMA 200$22.46BUY
Current $ZYME · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-06-03
Maintains
BuyBuy
Wells Fargo2026-05-08
Maintains
OverweightOverweight
Evercore ISI Group2026-03-09
Maintains
OutperformOutperform
HC Wainwright & Co.2026-03-06
Maintains
BuyBuy
Stifel2026-03-03
Maintains
BuyBuy
Leerink Partners2026-03-03
Maintains
OutperformOutperform
Wells Fargo2025-12-12
Upgrade ↑
Equal WeightOverweight
B. Riley Securities2025-11-21
Maintains
BuyBuy
Wells Fargo2025-11-19
Maintains
Equal WeightEqual Weight
Stifel2025-11-19
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Zymeworks Inc. (ZYME) stock. Of the recent 97 rating actions, 10 were upgrades and 6 were downgrades. 20 analysts currently cover ZYME.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

ZYME analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$310M

↑ 58.2% YoY

Revenue Next Year

$218M

↓ 29.5% YoY

EPS This Year

$1.57

EPS Next Year

$0.54

↓ 65.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ZYME EPS of $1.57 for the current fiscal year, based on estimates from 9 analysts. The ZYME revenue forecast is $310M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ZYME stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ZYME price target is $41.75 (+75.3% upside), with an analyst consensus of Buy.

The ZYME short-term stock prediction for tomorrow is $23.63 (-0.78%). The ZYME stock price prediction for 2027 estimates an average of $37. The ZYME stock prediction for 2030 projects a range of $57–$64.

Zymeworks Inc. trades on NASDAQ under the ticker ZYME. The ZYME stock outlook for 2027 is broadly positive, supported by a Buy consensus among 90% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ZYME forecast · 8 questions

According to 20 Wall Street analysts, the average 12-month ZYME price target is $41.75, with a high forecast of $48.00 and a low of $33.00. The median price target is shown in the chart above when available. This implies +75.3% potential upside from the current price of $23.82.

ZYME price targetWhat is ZYME price targetZYME analyst price targetZYME 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.